Management of a 4.4 cm Renal Cyst

Initial Diagnostic Workup

A 4.4 cm renal cyst requires immediate characterization with contrast-enhanced CT or MRI to determine if it is a simple cyst or a complex mass, as this size crosses the critical 4 cm threshold where malignancy risk increases and warrants closer evaluation 1, 2
Obtain multiphase contrast-enhanced imaging immediately, either CT or MRI, as ultrasound alone cannot reliably distinguish benign from malignant lesions or assess enhancement patterns, with MRI demonstrating superior specificity compared to CT (68.1% vs 27.7%) for characterizing renal lesions 2, 3, 4
The imaging must specifically assess degree and pattern of contrast enhancement 2, presence or absence of macroscopic fat 3, internal complexity (septations, nodules, calcifications) 5, and anatomic relationships and clinical stage 2
Obtain baseline laboratory studies including comprehensive metabolic panel with calculated GFR, complete blood count, urinalysis with proteinuria assessment, and chest imaging for metastatic evaluation 2

Simple cysts at 4.4 cm have essentially 0% malignancy risk but warrant follow-up imaging in 6-12 months to confirm stability given the size 1
Bosniak IIF lesions have ~10% malignancy risk 1
Bosniak III lesions have ~50% malignancy risk 1
Bosniak IV lesions have ~100% malignancy risk 1

If intervention is indicated based on imaging or biopsy results, partial nephrectomy is the standard of care for masses 4-7 cm (T1b) to preserve renal function and minimize chronic kidney disease risk 2
Radical nephrectomy may be considered if tumor location is unfavorable for partial nephrectomy or patient has increased surgical risk 2
Thermal ablation becomes less effective with higher complication rates for masses in the 4-7 cm range 1
Active surveillance may be appropriate for small solid masses <2 cm, but at 4.4 cm this is generally not recommended unless significant comorbidities limit life expectancy 1, 2

Do not assume a 4.4 cm cyst is benign without proper imaging characterization, as malignancy risk increases with complex features 1
A nondiagnostic biopsy cannot be considered evidence of benignity, and repeat biopsy should be considered if initial biopsy is nondiagnostic 5, 6, 4
Avoid CT without contrast as it markedly limits characterization, and only homogenous masses <20 HU or >70 HU or those with macroscopic fat can be characterized as benign without contrast 5, 6

Genetic counseling should be considered if the patient is ≤46 years old to evaluate for hereditary renal cell carcinoma syndromes 2